Grant: New Frontiers in Research Fund - Exploration
Dalhousie University
$125,000.00
Genetic engineering of T cells to target pathogenic antigen-presenting cells in Primary Biliary Cholangitis treatment
FY 2023-24
Program
New Frontiers in Research Fund - Exploration
Recipient
Location
Nova Scotia, Canada
Recipient Type
Academia
Type
Grant
Source
SSHRC's Expenditures File
As published
Cle
9993290
File number
NFRFE-2022-00882
Name nom
Sokke Umeshappa, Channakeshava
Role rôle
Applicant
Amount montant
125000.0
Fiscal year exercice financier
2023
Institution
Dalhousie University
Établissement
Dalhousie University
Province id
NS
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Competition year année du concours
2022
Title titre
Genetic engineering of T cells to target pathogenic antigen-presenting cells in Primary Biliary Cholangitis treatment
Keywords mots clés
Primary Biliary Cholangitis; Disease-specific treatment; Synthetic biology; Chimeric antigen receptor T cells; peptide-presenting MHC II molecules; Antigen-presenting cells; Chronic diseases; E2 component of the pyruvate dehydrogenase complex (PDC-E2)
Program
New Frontiers in Research Fund - Exploration
Programme
Fonds Nouvelles frontières en recherche - Exploration
Sshrc discipline en
Multiple primary field of research
Crsh discipline fr
Domaines de recherche principaux multiples
Sshrc main discipline
Multiple primary fields of research
Crsh discipline principale
Domaines de recherche principaux multiples
Sshrc area of research
Not Subject to Research Classification
Crsh domaine de recherche
Sans objet
Crdc field of research
Synthetic biology; Autoimmunity
Ccrd domaine de recherche
Biologie de synthèse; Auto-immunité
